{"id":669,"date":"2021-11-15T10:29:49","date_gmt":"2021-11-15T14:29:49","guid":{"rendered":"https:\/\/sites.bu.edu\/bbrain\/?p=669"},"modified":"2022-08-04T10:44:37","modified_gmt":"2022-08-04T14:44:37","slug":"propranolol-as-potential-treatment-for-neuroinflammation-in-gwi","status":"publish","type":"post","link":"https:\/\/sites.bu.edu\/bbrain\/2021\/11\/15\/propranolol-as-potential-treatment-for-neuroinflammation-in-gwi\/","title":{"rendered":"Propranolol as Potential Treatment for Neuroinflammation in GWI"},"content":{"rendered":"<p>Utilizing a mouse model of GWI, researchers examined the potential of <span>\u03b2-adrenergic (beta-adrenergic) receptor inhibitor and anti-inflammatory drug,\u00a0<\/span>propranolol<span>, as a treatment for GWI. Findings indicate that anti-neuroinflammatory drugs, such as proranolol, show promising potential in treating the underlying neuroimmune issues associated\u00a0with GWI.<\/span><\/p>\n<p><iframe loading=\"lazy\" width=\"600\" height=\"480\" src=\"https:\/\/reader.elsevier.com\/reader\/sd\/pii\/S0024320521009498?token=BCD09907E49F8BA950FBC4F51FAC5DA367577C18F100180298983892697BE1A097DA75B3D006D0D81BE82CFCE1A8DC07&amp;originRegion=us-east-1&amp;originCreation=20220804142733\"><span data-mce-type=\"bookmark\" style=\"display: inline-block; width: 0px; overflow: hidden; line-height: 0;\" class=\"mce_SELRES_start\">\ufeff<\/span><span data-mce-type=\"bookmark\" style=\"display: inline-block; width: 0px; overflow: hidden; line-height: 0;\" class=\"mce_SELRES_start\">\ufeff<\/span><span data-mce-type=\"bookmark\" style=\"display: inline-block; width: 0px; overflow: hidden; line-height: 0;\" class=\"mce_SELRES_start\">\ufeff<\/span><\/iframe><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Utilizing a mouse model of GWI, researchers examined the potential of \u03b2-adrenergic (beta-adrenergic) receptor inhibitor and anti-inflammatory drug,\u00a0propranolol, as a treatment for GWI. Findings indicate that anti-neuroinflammatory drugs, such as proranolol, show promising potential in treating the underlying neuroimmune issues associated\u00a0with GWI. \ufeff\ufeff\ufeff<\/p>\n","protected":false},"author":20663,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[6],"tags":[40,31,9],"_links":{"self":[{"href":"https:\/\/sites.bu.edu\/bbrain\/wp-json\/wp\/v2\/posts\/669"}],"collection":[{"href":"https:\/\/sites.bu.edu\/bbrain\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sites.bu.edu\/bbrain\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sites.bu.edu\/bbrain\/wp-json\/wp\/v2\/users\/20663"}],"replies":[{"embeddable":true,"href":"https:\/\/sites.bu.edu\/bbrain\/wp-json\/wp\/v2\/comments?post=669"}],"version-history":[{"count":2,"href":"https:\/\/sites.bu.edu\/bbrain\/wp-json\/wp\/v2\/posts\/669\/revisions"}],"predecessor-version":[{"id":671,"href":"https:\/\/sites.bu.edu\/bbrain\/wp-json\/wp\/v2\/posts\/669\/revisions\/671"}],"wp:attachment":[{"href":"https:\/\/sites.bu.edu\/bbrain\/wp-json\/wp\/v2\/media?parent=669"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sites.bu.edu\/bbrain\/wp-json\/wp\/v2\/categories?post=669"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sites.bu.edu\/bbrain\/wp-json\/wp\/v2\/tags?post=669"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}